Tanghe Pharma SRL
Tanghe Pharma reported total assets of €1.49m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jan 2026).
The score of Tanghe Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -17 % Total assets +20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tanghe Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 26 Jan 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 29 Jan 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
Tanghe Pharma's financial analysis
- Solvency36.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tanghe Pharma
Tanghe Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0848.766.826
- VAT number
- BE0848766826
- Peppol
- Registered · 0208:0848766826 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2012
- Registered office
- 1755 Pajottegem
- Latest accounts
- 2025 · filed on 26 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tanghe Pharma (SRL) has been based in Pajottegem since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 56,475 € and equity of 542,365 €; its revenue is not published. Its solvency stands at 36.3%, below the median of its sector (44.2%).
Companies similar to Tanghe Pharma
Companies in the same business, of comparable size and area, outside its group.
- Degrofarm Retail sale of pharmaceutical products Deinze · balance sheet €1.47m
- Omnicare Farma Dam Retail sale of pharmaceutical products Lokeren · balance sheet €1.25m
- Doba Farma Retail sale of pharmaceutical products Grimbergen · balance sheet €1.09m
- Antares Invest Retail sale of pharmaceutical products Celles (lez-Tournai) · balance sheet €1.80m
- Pharmacie Mathieu Retail sale of pharmaceutical products Sivry-Rance · balance sheet €1.46m
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- LA Roche Pharma Retail sale of pharmaceutical products La Roche-en-Ardenne · balance sheet €1.97m
- Pharmanext Retail sale of pharmaceutical products Ixelles · balance sheet €2.33m
Frequently asked questions about Tanghe Pharma
What is the revenue of Tanghe Pharma?
Tanghe Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tanghe Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0848766826 for Tanghe Pharma, if the company is VAT-registered. Its company number (CBE) is 0848.766.826.
Where is the registered office of Tanghe Pharma?
According to the CBE register, the registered office of Tanghe Pharma is in 1755 Pajottegem.
What is the equity of Tanghe Pharma?
At the close of the 2025 financial year, the equity of Tanghe Pharma amounts to 542,365 €, a solvency of 36.3% of total assets.
Who manages Tanghe Pharma?
The register lists 1 active mandates at Tanghe Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tanghe Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →